beta

XGN

Exagen Inc

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

exagen diagnostics, inc. is a patient focused, discovery driven, clia-certified, cap-accredited laboratory with a growing menu of proprietary, internally developed tests focusing in the area of rheumatology and autoimmune diseases. committed to personalized medicine, our avise tests are specifically designed to provide objective information to physicians and patients for more accurate, efficient diagnosis and better disease management. for more information on our company, please visit www.exagen.com. for more information on avise testing services, please visit www.avisetest.com.

Market Cap: 33.6 Million

Primary Exchange: NASDAQ

Website: http://www.exagen.com

Shares Outstanding: 17 Million

Float: 0

Dividend: 0.0 (0.0%)

Beta: 0.7213311914075221

Sector: Manufacturing

Industry: Dental Laboratories

Ethical Flags

Longest drawdown: 497 trading days

From: 2019-12-26 To: 2024-03-07

Lowest Point:

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided by IEX Cloud